Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 11 9 2019
medline: 28 3 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

To evaluate the performance of cervical cancer screening algorithms for women living with human immunodeficiency virus (HIV), using primary high-risk human papillomavirus (HPV) testing followed by cytology, visual inspection with acetic acid, or colposcopy. We conducted a prospective cohort study of women living with HIV in Botswana. All participants underwent high-risk HPV testing. Participants with positive high-risk HPV test results underwent cytology, visual inspection with acetic acid, colposcopy, and biopsy. Participants with negative high-risk HPV test results also underwent cytology. Histopathology was the reference standard for determination of preinvasive cervical disease and cervical cancer. Sensitivity, specificity, positive predictive value (PPV), negative predictive value, and likelihood ratios (LR) of high-risk HPV-based two-stage screening algorithms were calculated. Among 300 women screened, 88 (29%) had a positive high-risk HPV test result, and 29 of the 88 (35%) women who tested positive for high-risk HPV had CIN 2 or higher on histopathology. High-risk HPV followed by colposcopy resulted in a sensitivity of 83%, specificity of 49%, PPV of 47%, LR+ of +1.6, and LR- of -0.4. High-risk HPV followed by visual inspection with acetic acid resulted in a reduced sensitivity of 59%, specificity of 49%, PPV of 39%, LR+ of +1.2, and LR- of -0.8. High-risk HPV testing followed by cytology also resulted in a reduced sensitivity of 62%, specificity of 77%, PPV of 60%, LR+ of +2.7, and LR- of -0.5. Stratification by HPV 16/18/45 did not improve performance of the algorithms. In a high-risk population with HIV, high-risk HPV testing followed by colposcopy demonstrated the highest sensitivity and PPV in detecting high-grade cervical dysplasia. Allocating resources to colposcopy in resource-limited settings may be more effective than other screening strategies.

Identifiants

pubmed: 31503167
doi: 10.1097/AOG.0000000000003496
pmc: PMC6768725
mid: NIHMS1535901
pii: 00006250-201910000-00026
doi:

Types de publication

Editorial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

840-849

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI131924
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI060354
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States

Références

Obstet Gynecol. 1998 Jul;92(1):83-7
pubmed: 9649099
Int J Cancer. 2015 Aug 15;137(4):859-67
pubmed: 25631198
JAMA. 2007 Feb 28;297(8):813-9
pubmed: 17327523
Rev Obstet Gynecol. 2011;4(Suppl 1):S2-S11
pubmed: 21617785
BJOG. 2013 Jan;120(1):41-9
pubmed: 23121095
Lancet Oncol. 2012 Jun;13(6):607-15
pubmed: 22575588
Int J Gynaecol Obstet. 2016 Mar;132(3):252-8
pubmed: 26868062
Int J Cancer. 2007 Aug 1;121(3):621-32
pubmed: 17405118
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Vaccine. 2012 Nov 20;30 Suppl 5:F168-74
pubmed: 23199960
Vaccine. 2013 Dec 29;31 Suppl 5:F73-4
pubmed: 24331750
Am J Obstet Gynecol. 2000 Aug;183(2):383-8
pubmed: 10942474
N Engl J Med. 2007 Oct 18;357(16):1579-88
pubmed: 17942871
Lancet HIV. 2018 Jan;5(1):e45-e58
pubmed: 29107561
Int J Gynecol Pathol. 2011 Nov;30(6):591-6
pubmed: 21979597
Cancer Prev Res (Phila). 2012 Jan;5(1):11-7
pubmed: 22158053
J Med Virol. 2011 Oct;83(10):1689-95
pubmed: 21837784
Lancet Oncol. 2008 May;9(5):425-34
pubmed: 18407790
Infect Agent Cancer. 2014 Jul 08;9:22
pubmed: 25053972
Lancet. 2017 Feb 25;389(10071):871-880
pubmed: 27814964
Lancet Infect Dis. 2007 Jul;7(7):453-9
pubmed: 17597569
Front Oncol. 2014 Mar 14;4:48
pubmed: 24672770
N Engl J Med. 2009 Apr 2;360(14):1385-94
pubmed: 19339719
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:26-32
pubmed: 28691336
Obstet Gynecol Clin North Am. 2008 Dec;35(4):519-36; vii
pubmed: 19061814
Syst Rev. 2013 May 24;2:35
pubmed: 23706117
J Natl Cancer Inst. 1999 Feb 3;91(3):226-36
pubmed: 10037100
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
JAMA. 2000 Feb 23;283(8):1031-7
pubmed: 10697063
J Infect Dis. 2008 Feb 15;197(4):555-62
pubmed: 18237268
Int J Cancer. 2014 Jun 15;134(12):2902-9
pubmed: 24272364
Int J Cancer. 2014 Mar 15;134(6):1389-98
pubmed: 23929250
AIDS. 2013 Feb 20;27(4):607-15
pubmed: 23079814
Obstet Gynecol Int. 2009;2009:485423
pubmed: 19946640
Int J Cancer. 2015 Jul 1;137(1):127-34
pubmed: 25420434
N Engl J Med. 1997 Nov 6;337(19):1343-9
pubmed: 9358128
Chin J Cancer Res. 2017 Dec;29(6):496-509
pubmed: 29353972
Obstet Gynecol. 1994 Oct;84(4):591-7
pubmed: 8090399
J Natl Cancer Inst. 2009 Jan 21;101(2):88-99
pubmed: 19141778
Front Oncol. 2015 Nov 03;5:239
pubmed: 26579491
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252
J Glob Oncol. 2016 Oct 12;3(5):635-657
pubmed: 29094101
J Low Genit Tract Dis. 2016 Jul;20(3):218-23
pubmed: 27030883
Br J Cancer. 2003 Jan 13;88(1):63-73
pubmed: 12556961
AIDS. 2006 Nov 28;20(18):2337-44
pubmed: 17117020

Auteurs

Rebecca Luckett (R)

Botswana Harvard AIDS Initiative Partnership, Gaborone, Botswana; the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; the Department of Obstetrics and Gynaecology, University of Botswana, Gaborone, Botswana; Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Brigham and Women's Hospital, Boston, Massachusetts; the Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and the Botswana UPenn Partnership, Gaborone, Botswana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH